Ajooni Biotech Securities Confirmed Following Dematerialization Verification for Q1 2026

Ajooni Biotech Securities Confirmed Following Dematerialization Verification for Q1 2026

Ajooni Biotech Securities Confirmed Following Dematerialization Verification for Q1 2026​

Ajooni Biotech Limited has received confirmation regarding its securities following the completion of dematerialization processes for the quarter ended June 30, 2026. The certificate issued confirms various aspects of the company's holdings and the transition from physical to electronic shareholding.

The confirmation document verifies that the securities received from depository participants destined for dematerialization during the specified quarter were duly accepted or rejected by the relevant service provider. Furthermore, it confirms that these securities are listed on all stock exchanges where Ajooni Biotech’s previously issued shares stand listed.

Key aspects confirmed in the certificate include:

  • The physical security certificates received for dematerialization have been thoroughly verified and mutilated and cancelled following due verification by the depository participant.
  • The necessary substitutions of depositories' names into the register of members were completed as registered owners within the stipulated time frame, adhering to regulatory timelines.

This confirmation provides assurance regarding the status of Ajooni Biotech’s securities transition and record keeping for the period ending June 30, 2026.

AJOONI Stock Price Movement​

Edging higher as of 10:43 AM, the stock of Ajooni Biotech Limited is rallying strongly at ₹3.72 after climbing 1.36%. The company’s shares trade within an intraday range established between a low of ₹3.60 and a high of ₹3.72 on brisk volume of 242,171.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top